1. Home
  2. BIO vs MKSI Comparison

BIO vs MKSI Comparison

Compare BIO & MKSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$301.38

Market Cap

8.2B

Sector

Industrials

ML Signal

N/A

Logo MKS Instruments Inc.

MKSI

MKS Instruments Inc.

N/A

Current Price

$148.40

Market Cap

11.0B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
BIO
MKSI
Founded
1952
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Industrial Machinery/Components
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
11.0B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
BIO
MKSI
Price
$301.38
$148.40
Analyst Decision
Strong Buy
Buy
Analyst Count
4
10
Target Price
$358.50
$154.60
AVG Volume (30 Days)
163.5K
856.9K
Earning Date
10-29-2025
11-05-2025
Dividend Yield
N/A
0.56%
EPS Growth
N/A
820.97
EPS
N/A
4.12
Revenue
$2,557,500,000.00
$3,832,000,000.00
Revenue This Year
$1.77
$10.71
Revenue Next Year
$2.30
$7.30
P/E Ratio
N/A
$37.95
Revenue Growth
N/A
8.13
52 Week Low
$211.43
$54.84
52 Week High
$373.69
$170.37

Technical Indicators

Market Signals
Indicator
BIO
MKSI
Relative Strength Index (RSI) 40.11 44.28
Support Level $298.02 $153.12
Resistance Level $319.50 $160.78
Average True Range (ATR) 8.25 6.11
MACD -2.09 -1.68
Stochastic Oscillator 11.61 7.54

Price Performance

Historical Comparison
BIO
MKSI

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About MKSI MKS Instruments Inc.

MKS Inc formerly, MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others, used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.

Share on Social Networks: